# An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)

> **NCT06214832** · — · UNKNOWN · sponsor: **Hanlim Pharm. Co., Ltd.** · enrollment: 4000 (estimated)

## Conditions studied

- Hypertension

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06214832
- **Lead sponsor:** Hanlim Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-11
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-08-30
- **Target enrollment:** 4000 (ESTIMATED)
- **Last updated:** 2024-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06214832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06214832, "An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06214832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*